Javascript must be enabled to continue!
Assessment of Nitric Oxide Synthase Protein Level in the Scalp of Androgenetic Alopecia
View through CrossRef
Abstract
Background
Androgenetic alopecia (AGA) is the most common form of hair loss in males due to excessive response to androgens causing thinning of hair. Nitric oxide synthase is an enzyme catalyzing production of nitric oxide. Dihydrotestosterone induced nitric oxide synthase expression and NO production in dermal .papilla cells of the hair follicle
Objective
Investigation of the level of nitric oxide synthase protein expression in the scalp of men with androgenetic alopecia .and the possible link to the pathogenesis of androgenetic alopecia
Patients and Methods
A total of 40 patients were enrolled and divided into two equal groups; study group included 20 patients with androgenetic alopecia and control group included 20 healthy controls. A biopsy was taken from the androgenetic site and another from the non-androgenetic site in both patients and controls. A 3 mm punch is used to remove a small core of skin including epidermis and dermis. Tissue nitric oxide synthase. protein expression was compared between study groups
Results
Our study revealed that tissue nitric oxide synthase protein expression was statistically higher in androgenetic site in patients compared to non-androgenetic sites in patients 17.18±5 vs. 3.06±1.6 and higher in androgenetic sites of patients compared to androgenetic sites in controls. 17.18±5 vs. 3.32±0.8 respectively. Nitric oxide synthase at cut-off point 4.39 showed excellent discriminative power with 100% sensitivity and Also, Patients with Hypertension and on antihypertensive therapy had higher levels of nitric oxide synthase levels in androgenetic site compared to androgenetic sites of patients with AGA with or without systemic diseases other than hypertension. In our study, no significant correlations were detected between nitric oxide synthase and either of age or duration of disease in both androgenetic and non-androgenetic sites of patients with test values -0.236, 0.136, -0.157 and -0.119 respectively. On the other hand, no differences were noted between study groups regarding smoking and past history of surgical operations. Also, no significant difference between Nitric oxide synthase levels and grades of Hamilton scale in either. androgenetic or non-androgenetic sites of patients
Conclusion
Nitric oxide acts as a signaling molecule in human dermal papilla cells and implicate basal and androgen-mediated NO production to be involved in the regulation of hair follicle .activity
Oxford University Press (OUP)
Title: Assessment of Nitric Oxide Synthase Protein Level in the Scalp of Androgenetic Alopecia
Description:
Abstract
Background
Androgenetic alopecia (AGA) is the most common form of hair loss in males due to excessive response to androgens causing thinning of hair.
Nitric oxide synthase is an enzyme catalyzing production of nitric oxide.
Dihydrotestosterone induced nitric oxide synthase expression and NO production in dermal .
papilla cells of the hair follicle
Objective
Investigation of the level of nitric oxide synthase protein expression in the scalp of men with androgenetic alopecia .
and the possible link to the pathogenesis of androgenetic alopecia
Patients and Methods
A total of 40 patients were enrolled and divided into two equal groups; study group included 20 patients with androgenetic alopecia and control group included 20 healthy controls.
A biopsy was taken from the androgenetic site and another from the non-androgenetic site in both patients and controls.
A 3 mm punch is used to remove a small core of skin including epidermis and dermis.
Tissue nitric oxide synthase.
protein expression was compared between study groups
Results
Our study revealed that tissue nitric oxide synthase protein expression was statistically higher in androgenetic site in patients compared to non-androgenetic sites in patients 17.
18±5 vs.
3.
06±1.
6 and higher in androgenetic sites of patients compared to androgenetic sites in controls.
17.
18±5 vs.
3.
32±0.
8 respectively.
Nitric oxide synthase at cut-off point 4.
39 showed excellent discriminative power with 100% sensitivity and Also, Patients with Hypertension and on antihypertensive therapy had higher levels of nitric oxide synthase levels in androgenetic site compared to androgenetic sites of patients with AGA with or without systemic diseases other than hypertension.
In our study, no significant correlations were detected between nitric oxide synthase and either of age or duration of disease in both androgenetic and non-androgenetic sites of patients with test values -0.
236, 0.
136, -0.
157 and -0.
119 respectively.
On the other hand, no differences were noted between study groups regarding smoking and past history of surgical operations.
Also, no significant difference between Nitric oxide synthase levels and grades of Hamilton scale in either.
androgenetic or non-androgenetic sites of patients
Conclusion
Nitric oxide acts as a signaling molecule in human dermal papilla cells and implicate basal and androgen-mediated NO production to be involved in the regulation of hair follicle .
activity.
Related Results
The psychosocial burden of androgenetic alopecia in Saudi Arabia: A cross-sectional study
The psychosocial burden of androgenetic alopecia in Saudi Arabia: A cross-sectional study
Background:
The most prevalent cause of hair loss is androgenetic alopecia. Improved therapeutic modalities may result from knowing how stress affects hair grow...
Validation of alopecia coding in US claims data among women of childbearing age
Validation of alopecia coding in US claims data among women of childbearing age
AbstractBackgroundAccurately identifying alopecia in claims data is important to study this rare medication side effect.ObjectivesTo develop and validate a claims‐based algorithm t...
The potential of androgenic alopecia management from plant derivatives
The potential of androgenic alopecia management from plant derivatives
Hair loss or alopecia is a common dermatological issue that can affect millions of human
population of all ages and both gender, male and female. Frequently, alopecia has been
foun...
Role of Dutasteride in the Treatment of Androgenetic Alopecia
Role of Dutasteride in the Treatment of Androgenetic Alopecia
This study evaluates the role of dutasteride in the treatment of androgenetic alopecia. A prospective, open-labeled interventional study conducted at the Department of Dermatology ...
clinical trial efficacy of autologous cellular micrografts in androgenic alopecia
clinical trial efficacy of autologous cellular micrografts in androgenic alopecia
Abstract
Purpose: Autologous cellular micrografts (ACM) is a novel treatment method in hair loss and androgenic alopecia. Androgenetic alopecia, androgenic alopecia, patter...
Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
Alopecia, or hair loss, is a common medical condition that can affect anyone, regardless of age and sex. Although it
is not a life-threateningcondition, it can strongly affect a pe...
Induction of hepatic ito cell nitric oxide production after acute endotoxemia
Induction of hepatic ito cell nitric oxide production after acute endotoxemia
Nitric oxide is a highly reactive mediator released in the liver by hepatocytes, Kupffer cells and endothelial cells during endotoxin-induced inflammation. In this study we determi...
RETRACTED: Causal effects of omega‐6 and LDL‐C on androgenetic alopecia: A Mendelian randomization study
RETRACTED: Causal effects of omega‐6 and LDL‐C on androgenetic alopecia: A Mendelian randomization study
Abstract
Background
Increasing studies have reported a causal relationship between androgenetic alopecia (AGA) and lipid‐...

